News

CGBIO(CEO Hyun Seung Yu), a leading Korean company specializing in bio-regenerative medicine, proudly announces that its ...
Orchestra BioMed Holdings shares rallied premarket after the maker of medical devices said a blood-pressure mechanism received breakthrough status from the U.S. Food and Drug Administration, allowing ...
Mursla Bio, a leader in Extracellular Vesicle (EV) science on a mission to significantly improve cancer outcomes for at-risk ...
Medical device maker ICU Medical changed the designs of infusion pumps made in Minnesota without properly clearing important ...
U.S. Food and Drug Administration approvals of life-changing, high-risk medical devices reportedly slowed to a 10-year low for the January to March period, as recent layoffs have reportedly had ...
Get Instant Summarized Text (Gist) The FDA's approval of high-risk medical devices has reached a 10-year low, attributed to significant workforce reductions. Despite an increase in pending ...
The question is not whether AI will transform healthcare; it’s whether regulators can keep pace with that transformation.
The US FDA is coping with a series of Trump-imposed job cuts. These are starting to hamper food safety and pharmaceutical ...
The US FDA has approved EBR System's leadless pacemaker WISE, the only heart device able to deliver left-ventricle ...
Tim Boreham sharpens his knifes to look under the hood at cardiac pacing device innovator EBR Systems after its US FDA ...
Epiminder, a pioneering medical device and information solutions company, today announced that it has been granted FDA authorisation via the De Novo classification for Minder, its proprietary ...